Financhill
Back

Chemomab Therapeutics Quote, Financials, Valuation and Earnings

Chemomab Therapeutics Price Quote

$0.69
-0.02 (-1.43%)
(Updated: May 2, 2024 at 5:57 AM ET)

Chemomab Therapeutics Key Stats

Sell
49
Chemomab Therapeutics (CMMB) is a Sell

Day range:
$0.66 - $0.72
52-week range:
$0.42 - $1.89
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
59.2K
Avg. volume:
41.1K
1-year change:
-52.24%
Market cap:
$10.1M
Revenue:
$0
EPS:
$-2.94

How Much Does Chemomab Therapeutics Make?

Data Unavailable

Is Chemomab Therapeutics Growing As A Company?

Data Unavailable

Chemomab Therapeutics Stock Price Performance

What Is Chemomab Therapeutics 52-Week High & Low?

Chemomab Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Chemomab Therapeutics?

Is Chemomab Therapeutics Cash Flow Positive?

  • What Is CMMB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$25.6M
  • What Is Chemomab Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $538K
  • What Is Chemomab Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $25.6M

Chemomab Therapeutics Return On Invested Capital

Data Unavailable

Chemomab Therapeutics Earnings Date & Stock Price

Chemomab Therapeutics Competitors

Chemomab Therapeutics Dividend Yield

Data Unavailable

Chemomab Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 35%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 880.67%

Major Shareholders

  • How many CMMB shares are owned by institutional investors?
    2.8M CMMB shares are owned by institutional investors
  • How many CMMB shares are owned by insiders?
    339.4K CMMB shares are owned by insiders